Natural compounds that regulate lymph node sinus macrophages: Inducing an anti-tumor effect by regulating macrophage activation.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Clinical and Experimental Hematopathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3960/jslrt.17032PMID 29553092PMCID PMC6144196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophages.

  2017cited by this paper
• Possible functions of CD169‐positive sinus macrophages in lymph nodes in anti‐tumor immune responses

  2017cited by this paper
• Tumour-associated macrophages as treatment targets in oncology

  2017cited by this paper
• The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer

  2016cited by this paper
• Onionin A, a sulfur-containing compound isolated from onions, impairs tumor development and lung metastasis by inhibiting the protumoral and immunosuppressive functions of myeloid cells.

  2016cited by this paper
• SCS macrophages suppress melanoma by restricting tumor-derived vesicle–B cell interactions

  2016cited by this paper
• Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages

  2016cited by this paper
• Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy.

  2016cited by this paper
• Lymph node – an organ for T‐cell activation and pathogen defense

  2016cited by this paper
• Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01

  2016cited by this paper
• Prognostic significance of CD169‐positive lymph node sinus macrophages in patients with endometrial carcinoma

  2016cited by this paper
• A Breakthrough: Macrophage-Directed Cancer Immunotherapy.

  2016cited by this paper
• Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma

  2015cited by this paper
• CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells

  2015cited by this paper
• Nanogel-based immunologically stealth vaccine targets macrophages in the medulla of lymph node and induces potent antitumor immunity.

  2014cited by this paper
• CD169 mediates the capture of exosomes in spleen and lymph node.

  2014cited by this paper
• Clinical significance of macrophage heterogeneity in human malignant tumors

  2013cited by this paper
• Sialoadhesin – a macrophage‐restricted marker of immunoregulation and inflammation

  2013cited by this paper
• CD169‐positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma

  2013cited by this paper
• Regulation of type I interferon responses

  2013cited by this paper
• Antigen Delivery to Macrophages Using Liposomal Nanoparticles Targeting Sialoadhesin/CD169

  2012cited by this paper
• CD169+ macrophages at the crossroads of antigen presentation.

  2012cited by this paper
• Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription‐3 and nuclear factor‐kappa B in tumor cells and tumor‐associated macrophages

  2011cited by this paper
• The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

  2011cited by this paper
• CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens.

  2011cited by this paper
• Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.

  2011cited by this paper
• Delivery of antigen to sialoadhesin or CD163 improves the specific immune response in pigs.

  2011cited by this paper
• Immune regulation by apoptotic cell clearance

  2010cited by this paper
• Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients

  2007cited by this paper
• Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells

  2007cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan

  2006cited by this paper
• Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis.

  2006cited by this paper
• Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis

  2006cited by this paper
• CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas.

  2006cited by this paper
• Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations.

  2001cited by this paper
• CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

  1998cited by this paper
• Lymph nodes and human tumors (review).

  1998cited by this paper

• In vitro experiments and network pharmacology-based investigation of the molecular mechanism of neferine in the treatment of gastric cancer

  2025cites this paper
• Anticancer immune reaction and lymph node sinus macrophages: a review from human and animal studies

  2024cites this paper
• Naringenin counteracts LPS-induced inflammation and immune deficits in chicken thymus by alleviating mtROS/ferroptosis levels

  2024cites this paper
• Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy

  2023cites this paper
• Research progress on the anti-tumor effect of Naringin

  2023cites this paper
• Hairy root culture: a potent method for improved secondary metabolite production of Solanaceous plants

  2023cites this paper
• Dysfunction of sinus macrophages in tumor‐bearing host induces resistance to immunotherapy

  2023cites this paper
• Cytotoxic, antioxidant, and antiglycation activities, and tyrosinase inhibition using silver nanoparticles synthesized by leaf extract of Solanum aculeatissimum Jacq

  2023cites this paper
• Mechanisms and characteristics of subcapsular sinus macrophages in tumor immunity: a narrative review

  2023cites this paper
• Subtilase cytotoxin from Shiga-toxigenic Escherichia coli impairs the inflammasome and exacerbates enteropathogenic bacterial infection

  2022influential citation
• Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration

  2022cites this paper
• Tumor-associated macrophages: Potential target of natural compounds for management of breast cancer.

  2022cites this paper
• Immunoregulatory properties of a crude extraction fraction rich in polysaccharide from Chrysanthemum zawadskii Herbich var. latilobum and its potential role as a vaccine adjuvant.

  2021cites this paper
• Targeting the tumor immwpune microenvironment with "nutraceuticals": From bench to clinical trials.

  2020cites this paper
• Targeting Tumor-Associated Macrophages by Plant Compounds

  2020cites this paper
• Preparation of fibrin hydrogels to promote the recruitment of anti-inflammatory macrophages.

  2019cites this paper
• Targeting Lymph Node Sinus Macrophages to Inhibit Lymph Node Metastasis

  2019cites this paper
• High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer

  2018cites this paper